Stock comparison
ILLUMINA, INC. is 23.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($28.78 B vs $1.23 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ILMN is larger
ILLUMINA, INC. is 23.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($28.78 B vs $1.23 B).
Market value leader
ILMN
ILLUMINA, INC. is 23.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($28.78 B vs $1.23 B).
Revenue leader
ILMN
EYPT: $31.37M vs ILMN: $4.34B.
Profit leader
ILMN
EYPT: -$231.96M vs ILMN: $850.00M.
Margin leader
ILMN
EYPT: -739.4% vs ILMN: 19.6% net margin.
| Metric | EYPT | ILMN |
|---|---|---|
| Market cap | $1.23 B | $28.78 B |
| US-listed rank | #2501 | #485 |
| Revenue (latest FY) | $31.37M | $4.34B |
| Net income (latest FY) | -$231.96M | $850.00M |
| Net margin | -739.4% | 19.6% |
| P/E (trailing FY) | - | 33.9x |
| SEC filings | 1,308 | 3,713 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ILLUMINA, INC. is 23.3x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($28.78 B vs $1.23 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while ILLUMINA, INC. reported $4.34B.
Full pages: EyePoint Pharmaceuticals, Inc. and ILLUMINA, INC., or browse the full rankings.